William Blair & Company’s Immunomedics Inc IMMU Stock Holding History

William Blair & Company’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-20,000	Closed	-$1.7M	–	1895
2020 Q3	$1.7M	Hold	20,000	–	–	0.01%	620
2020 Q2	$709K	Hold	20,000	–	–	﹤0.01%	828
2020 Q1	$270K	Hold	20,000	–	–	﹤0.01%	1055
2019 Q4	$423K	Hold	20,000	–	–	﹤0.01%	1049
2019 Q3	$265K	Buy	20,000 +5,000	+33%	+$73.5K	﹤0.01%	1172
2019 Q2	$267K	Hold	15,000	–	–	﹤0.01%	1191
2019 Q1	$288K	Buy	+15,000	New	+$242K	﹤0.01%	1159

William Blair & Company's IMMU Position: Q4 2020 in Review

William Blair & Company sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 20,000 shares — an estimated $1.7M sold.

William Blair & Company first reported a position in IMMU in Q1 2019 and held it in 7 quarters. The position peaked at $1.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

William Blair & Company reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
William Blair & Company sold 20,000 Immunomedics Inc shares in Q4 2020, an estimated $1.7M.
William Blair & Company first reported a position in Immunomedics Inc in Q1 2019 and held it in 7 quarters.
William Blair & Company's Immunomedics Inc position peaked at $1.7M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on William Blair & Company's 13F filing for Q4 2020, filed 9 Feb 2021.